0222

COM:OPTIMAX2U

Optimax Eye Specialist

  • Stock

Last Close

0.66

12/11 08:50

Market Cap

374.88M

Beta: -

Volume Today

44.60K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
Dec '23
net income
18.59M
-
23.50M
26.43%
20.01M
14.87%
depreciation and amortization
6.58M
-
7.82M
18.84%
9.88M
26.30%
deferred income tax
stock based compensation
change in working capital
-1.43M
-
1.29M
190.20%
998K
22.52%
accounts receivables
-3.11M
-
2.01M
164.70%
-635K
131.53%
inventory
-850K
-
-1.22M
43.65%
-758K
37.92%
accounts payables
other working capital
-205K
-
-404K
97.07%
255K
163.12%
other non cash items
1.07M
-
1.12M
5.15%
1.23M
9.98%
net cash provided by operating activities
19.69M
-
27.05M
37.39%
25.30M
6.49%
investments in property plant and equipment
-11.08M
-
-11.12M
0.30%
-11.81M
6.21%
acquisitions net
-42K
-
purchases of investments
-104K
-
sales maturities of investments
10.70M
-
other investing activites
-18K
-
-18K
0%
-21K
16.67%
net cash used for investing activites
-295K
-
-11.24M
3,709.83%
-9.87M
12.18%
debt repayment
-515K
-
-591K
14.76%
-343K
41.96%
common stock issued
1K
-
1.98M
198,000%
common stock repurchased
dividends paid
-5.13M
-
-11.61M
126.32%
-9.74M
16.11%
other financing activites
-1.19M
-
-1.25M
5.23%
658K
152.72%
net cash used provided by financing activities
-10.71M
-
-16.14M
50.62%
-17.47M
8.27%
effect of forex changes on cash
-2K
-
net change in cash
8.68M
-
-323K
103.72%
-2.05M
533.44%
cash at beginning of period
9.84M
-
18.52M
88.20%
18.20M
1.74%
cash at end of period
18.52M
-
18.20M
1.74%
16.16M
11.24%
operating cash flow
19.69M
-
27.05M
37.39%
25.30M
6.49%
capital expenditure
-11.08M
-
-11.12M
0.30%
-11.81M
6.21%
free cash flow
8.61M
-
15.94M
85.15%
13.49M
15.34%

All numbers in (except ratios and percentages)